|
|
||||||||
Articles |
Departments of
1
Pathology and
2
Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287.
a Address correspondence to this author at: Department of Pathology, Johns Hopkins Medical Institutions, 600 N. Wolfe St., Meyer B-125, Baltimore, MD 21287. Fax 410-614-7609; e-mail: lsokoll{at}jhmi.edu
Background: Immunoassays for parathyroid hormone (PTH), with short incubation times and results available in <15 min, have allowed intraoperative monitoring of the success of parathyroid surgery. The purpose of this study was to evaluate the analytical performance of a rapid PTH assay and its clinical performance in a series of 200 patients.
Methods: PTH was measured with a modified immunochemiluminometric assay with a 7-min incubation time (QuiCk-IntraOperativeTM Intact PTH assay). The rapid assay was compared with results in a central laboratory (immunoradiometric assay) in 44 EDTA-plasma specimens. The rapid assay was used intraoperatively in 200 consecutive cases with specimens analyzed before and 510 min after resection of the hypersecreting parathyroid gland(s).
Results: Intraassay imprecision was 12% at 28 ng/L and 11% at 278 ng/L. Regression analysis of results of the rapid PTH assay and the IRMA PTH assay in 44 parathyroidectomy patients yielded y = 1.26x - 12 ng/L, Sy|x = 26.3 ng/L, r = 0.984, and in 40 of 44 patients with values <200 ng/L, y = 1.02x + 1.9, Sy|x = 13.9, r = 0.947. In the 195 cases using intraoperative PTH testing with complete results and defined clinical outcomes, the overall accuracy of the assay in predicting surgical success was 88% using the criterion of a 50% decrease at 510 min and 97% including the subset of patients with delayed decreases of PTH.
Conclusions: The rapid PTH assay had excellent analytical performance and excellent agreement with the PTH immunoradiometric assay and predicted the success of parathyroid surgery in this large series of consecutive patients.
The following articles in journals at HighWire Press have cited this article:
![]() |
P Iglesias and J J Diez Current treatments in the management of patients with primary hyperparathyroidism Postgrad. Med. J., January 1, 2009; 85(999): 15 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maweja, F. Sebag, J. Hubbard, R. Giorgi, and J. F. Henry Immediate and Medium-Term Results of Intraoperative Parathyroid Hormone Monitoring During Video-Assisted Parathyroidectomy Arch Surg, December 1, 2004; 139(12): 1301 - 1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-F. Chou, C.-H. Lee, J.-B. Chen, K.-T. Hsu, and S.-M. Sheen-Chen Intraoperative Parathyroid Hormone Measurement in Patients With Secondary Hyperparathyroidism Arch Surg, March 1, 2002; 137(3): 341 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Johnson, G. Doherty, T. Lairmore, J. F. Moley, L. M. Brunt, J. Koenig, and M. G. Scott Evaluation of the Performance and Clinical Impact of a Rapid Intraoperative Parathyroid Hormone Assay in Conjunction with Preoperative Imaging and Concise Parathyroidectomy Clin. Chem., May 1, 2001; 47(5): 919 - 925. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |